bioRxiv preprint doi: https://doi.org/10.1101/2020.10.27.357053; this version posted October 27, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license. Blood gene expression-based prediction of lethality after respiratory infection by influenza A virus in mice Authors: Pedro Milanez-Almeida1,2,*, Andrew J. Martins1, Parizad Torabi-Parizi1,3, Luis M. Franco1,4, John S. Tsang1,2, Ronald N. Germain1,2,* 1 Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda MD 2 Center for Human Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda MD 3 Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda MD 4 Present affiliation: Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda MD *Correspondence to:
[email protected] and
[email protected] bioRxiv preprint doi: https://doi.org/10.1101/2020.10.27.357053; this version posted October 27, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license. Abstract Lethality after respiratory infection with influenza A virus (IAV) is associated with potent immune activation and lung tissue damage.